Clinical predictors of longer survival in patients with BRAFV600-mutated metastatic melanoma receiving immunotherapy prior to BRAF/MEK inhibition in the metastatic setting.

被引：0
|
作者：
Kahn, Adriana Matutino
Perry, Curtis
Etts, Katrina
Kluger, Harriet M.
Sznol, Mario
机构：
[1] Yale Sch Med, New Haven, CT USA
[2] Yale New Haven Med Ctr, New Haven, CT USA
[3] Yale Univ, Sch Med, Yale New Haven Hosp, Yale Canc Ctr,Smilow Canc Hosp, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9555
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Successful retreatment with combined BRAF/MEK inhibition in metastatic BRAFV600-mutated melanoma
    Amann, V. C.
    Hoffmann, D.
    Mangana, J.
    Dummer, R.
    Goldinger, S. M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (10) : 1638 - 1640
  • [2] Clinical Predictors of Survival in Patients With BRAFV600-Mutated Metastatic Melanoma Treated With Combined BRAF and MEK Inhibitors After Immune Checkpoint Inhibitors
    Kahn, Adriana M.
    Perry, Curtis J.
    Etts, Katrina
    Kluger, Harriet
    Sznol, Mario
    [J]. ONCOLOGIST, 2024, 29 (04): : e507 - e513
  • [3] Impact of gene expression profiles on clinical predictors of survival in patients (pts) with BRAFV600-mutated metastatic melanoma (mM)
    Larkin, James M. G.
    Lewis, Karl D.
    Ribas, Antoni
    Flaherty, Keith
    Ascierto, Paolo Antonio
    Dreno, Brigitte
    Mckenna, Edward Francis
    Zhu, Qian
    Mun, Yong
    Hauschild, Axel
    McArthur, Grant A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [4] Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitors
    Falanga, Anna
    Marchetti, Marina
    Massi, Daniela
    Merelli, Barbara
    Verzeroli, Cristina
    Russo, Laura
    Rulli, Eliana
    Tondini, Carlo
    Legramandi, Lorenzo
    Nassini, Romina
    Scatena, Cristian
    De Logu, Francesco
    Cattaneo, Laura
    Mandala, Mario
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (06) : 1254 - 1256
  • [5] Baseline Genomic Features in BRAFV600-Mutated Metastatic Melanoma Patients Treated with BRAF Inhibitor plus MEK Inhibitor in Routine Care
    Louveau, Baptiste
    Jouenne, Fanelie
    de Moura, Coralie Reger
    Sadoux, Aurelie
    Baroudjian, Barouyr
    Delyon, Julie
    Herms, Florian
    De Masson, Adele
    Da Meda, Laetitia
    Battistella, Maxime
    Dumaz, Nicolas
    Lebbe, Celeste
    Mourah, Samia
    [J]. CANCERS, 2019, 11 (08)
  • [6] An imaging study of vemurafenib in patients with BRAFV600-mutated metastatic melanoma.
    Lastoria, Secondo
    Grimaldi, Antonio M.
    Aloj, Luigi
    Simeone, Ester
    Romano, Anna
    Caraco, Corradina
    Curvietto, Marcello
    Esposito, Assunta
    Caraco, Corrado
    Mozzillo, Nicola
    Torri, Valter
    Ascierto, Paolo Antonio
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [7] Case report: A case of metastatic BRAFV600-mutated melanoma with heart failure treated with immune checkpoint inhibitors and BRAF/MEK inhibitors
    Nishizawa, Aya
    Kawakami, Misaki
    Kitahara, Yasuyuki
    [J]. FRONTIERS IN ONCOLOGY, 2024, 14
  • [8] Treatment of BRAF-mutated metastatic melanoma patients with targeted therapy combinations or immunotherapy in real world setting.
    Ocvirk, Janja
    Ignjatovic, Marija
    Rebersek, Martina
    Boc, Marko
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [9] Genomic Features of Exceptional Response in Vemurafenib ± Cobimetinib-treated Patients with BRAFV600-mutated Metastatic Melanoma
    Yan, Yibing
    Wongchenko, Matthew J.
    Robert, Caroline
    Larkin, James
    Ascierto, Paolo A.
    Dreno, Brigitte
    Maio, Michele
    Garbe, Claus
    Chapman, Paul B.
    Sosman, Jeffrey A.
    Shi, Zhen
    Koeppen, Hartmut
    Hsu, Jessie J.
    Chang, Ilsung
    Caro, Ivor
    Rooney, Isabelle
    McArthur, Grant A.
    Ribas, Antoni
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (11) : 3239 - 3246
  • [10] Remarkable response of BRAFV600E-mutated metastatic pancreatic cancer to BRAF/MEK inhibition: a case report
    Li, Hong-Shuai
    Yang, Ke
    Wang, Yan
    [J]. GASTROENTEROLOGY REPORT, 2022, 10
12345